{"member_organisations": "https://www.pharmamar.com/wp-content/uploads/2017/02/Patients-associations-2016.pdf \n \nhttps://www.pharmamar.com/es/ciencia-e-innovacion/colaboracion-con-asociaciones-cientificas/", "identification_number": "840804329063-93", "fields_of_interest": "Business and Industry, Research and innovation", "head_office_address": "Av. de los Reyes, 1 Colmenar Viejo", "full_time_equivalent_fte": "0,25", "person_with_legal_responsibility": "JOSE MARIA FERNANDEZ SOUSA-FARO", "inter_groups": "", "financial_year_start_date": "01/01/2016", "grants": "178747", "head_office_country": "Spain", "eu_initiatives": "Pol\u00edtica de investigaci\u00f3n \nEMA \nFinanciaci\u00f3n a la investigaci\u00f3n y desarrollo", "organisation_name": "Pharma Mar, S.A. (PharmaMar)", "belgium_office_post_code": "", "number_of_persons_involved": "1", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "", "subsection": "Companies & groups", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "22/11/2017", "website_address": "", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "MADRID", "membership": "EBE \nEFPIA", "head_office_post_code": "28770", "goals__remit": "PharmaMar is a company focused on oncology and committed to research and development which takes inspiration from the sea to discover molecules with antitumor activity. We are an integrated company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. \n \nPharmaMar\u2019s commitment to patients and to research has made it a world leader in the discovery of antitumor drugs of marine origin.", "industry_forums": "", "head_office_phone": "(+34)918466000", "level_of_interest": "European", "relevant_communication": "Horizon2020 \nDrug Approval procedures", "financial_year_end_date": "01/12/2016", "estimate_of_costs_as_a_range": "50000-99999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "S.A.", "person_in_charge_of_eu_relations": "Carmen  Guijarro", "customers": "", "belgium_office_post_box": "", "position": "Directora Dpto. Coordinaci\u00f3n Proyectos"}